Columns Layout = 2
ACO Name and Location
Einstein Care Partners, LLC
3300 Henry Avenue
Falls 2 Suite 601
Philadelphia, Pennsylvania 19129-1121
ACO Primary Contact
Primary Contact Phone Number |
215-774-4134
|
Organizational Information
ACO Participants:
Fornance Physician Services Inc |
N |
Einstein Practice Plan Inc |
N |
ACO Governing Body:
Nicholas, MD
|
Angela
|
Co-Chair
|
1
|
ACO Participant Representative
|
Fornance Physician Services
|
Sivak, MD |
Steven |
Co-Chair |
1 |
ACO Participant Representative |
Einstein Practice Plan |
Behme, MD |
Matthew |
Member |
1 |
ACO Participant Representative |
Einstein Practice Plan |
Datner, MD |
Elizabeth |
Member |
1 |
ACO Participant Representative
|
Einstein Practice Plan
|
Dubois |
Ruth |
Member |
1 |
Medicare Beneficiary Representative
|
|
Duffy
|
Beth
|
Member
|
1
|
ACO Participant Representative
|
Fornace Physician Services
|
Gulati, MD
|
Rohit
|
Member
|
1 |
ACO Participant Representative
|
Einstein Practice Plan
|
James |
Dixie |
Member |
1 |
Other |
Albert Einstein Medical Center |
Johnson, MD |
Ahashta |
Member |
1 |
ACO Participant Representative |
Fornance Physician Services
|
Leighton, MD |
John |
Member |
1 |
ACO Participant Representative |
Einstein Practice Plan |
Levitan |
Ken |
Member |
1 |
Other |
Einstein Healthcare Network |
Rose, MD |
Gina |
Member |
1 |
ACO Participant Representative |
Fornance Physician Services
|
Scaven, MD |
Christopher |
Member |
1 |
ACO Participant Representative |
Einstein Community Health Associates |
Chandrasekaran, MD
|
Shivanandh
|
Member
|
0
|
Other
|
Einstein Care Partners, LLC
|
Key ACO Clinical and Administrative Leadership:
Shivanandh Chandrasekaran, MD
|
Medical Director
|
Marianne DeJesus
|
Compliance Officer
|
Associated Committees and Committee Leadership:
Clinical Performance and Integration Committee
|
Jason Aronovitz, DO (Co-Chairperson) and Shivanandh Chandrasekaran, MD (Co-Chairperson)
|
Membership and Nominating Committee
|
Angela Nicholas, MD (Co-Chairperson) and Steven Sivak, MD (Co-Chairperson)
|
Types of ACO Participants, or Combinations of Participants, That Formed The ACO:
- ACO professionals in a group practice arrangement
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
Third Agreement Period
- Performance Year 2020: $6,273,203
Second Agreement Period
- Performance Year 2019: $0
First Agreement Period
- Performance Year 2018: $1,905,474
Shared Savings Distribution
Third Agreement Period
Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 80%
Second Agreement Period
Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
First Agreement Period
Performance Year 2019
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 80%
Quality Performance Results
2020 Quality Performance Results
ACO-43 |
Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI #91)
|
0.79 |
0.95 |
ACO-13
|
Falls: Screening for Future Fall Risk
|
86.27 |
84.97 |
ACO-14
|
Preventative Care and Screening: Influenza Immunization
|
60.30 |
76.03 |
ACO-17
|
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
|
79.10 |
81.67 |
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
ACO Participation Waiver:
The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.
- Parties to the arrangement: ACO and ACO Participants listed above
- Date of arrangement: January 1, 2018
- Items, services, goods, or facility provided: ACO provides administrative and analytic support to ACO Participants.
- Date and nature of any amendments to the arrangement, if applicable: N/A
Download this information in a document (PDF) here.